BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26682950)

  • 1. Time-Series Expression of Toll-Like Receptor 4 Signaling in Septic Mice Treated with Mesenchymal Stem Cells.
    Wu KH; Wu HP; Chao WR; Lo WY; Tseng PC; Lee CJ; Peng CT; Lee MS; Chao YH
    Shock; 2016 Jun; 45(6):634-40. PubMed ID: 26682950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis.
    Chao YH; Wu HP; Wu KH; Tsai YG; Peng CT; Lin KC; Chao WR; Lee MS; Fu YC
    PLoS One; 2014; 9(10):e110338. PubMed ID: 25337817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PG2, a botanically derived drug extracted from Astragalus membranaceus, promotes proliferation and immunosuppression of umbilical cord-derived mesenchymal stem cells.
    Chao YH; Wu KH; Lin CW; Yang SF; Chao WR; Peng CT; Wu HP
    J Ethnopharmacol; 2017 Jul; 207():184-191. PubMed ID: 28648928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor signalling associated with immunomodulation of umbilical cord-derived mesenchymal stem cells in mice with systemic lupus erythematosus.
    Wu KH; Cheng CC; Li JP; Weng TF; Yang SF; Pan HH; Chao YH
    Lupus; 2020 Feb; 29(2):165-175. PubMed ID: 31964222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis.
    Mei SH; Haitsma JJ; Dos Santos CC; Deng Y; Lai PF; Slutsky AS; Liles WC; Stewart DJ
    Am J Respir Crit Care Med; 2010 Oct; 182(8):1047-57. PubMed ID: 20558630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation via MyD88-NFκB Signaling Pathway from Human Umbilical Cord-Derived Mesenchymal Stem Cells in Acute Lung Injury.
    Wu KH; Li JP; Chao WR; Lee YJ; Yang SF; Cheng CC; Chao YH
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pellino-3 promotes endotoxin tolerance and acts as a negative regulator of TLR2 and TLR4 signaling.
    Murphy MB; Xiong Y; Pattabiraman G; Manavalan TT; Qiu F; Medvedev AE
    J Leukoc Biol; 2015 Dec; 98(6):963-74. PubMed ID: 26310831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo monitoring of dynamic interaction between neutrophil and human umbilical cord blood-derived mesenchymal stem cell in mouse liver during sepsis.
    Ahn SY; Maeng YS; Kim YR; Choe YH; Hwang HS; Hyun YM
    Stem Cell Res Ther; 2020 Feb; 11(1):44. PubMed ID: 32014040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis.
    Li P; Guo Y; Bledsoe G; Yang ZR; Fan H; Chao L; Chao J
    Crit Care; 2015 May; 19(1):200. PubMed ID: 25930108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory intervention with Gamma interferon in mice with sepsis.
    Wang Y; Kong BB; Yang WP; Zhao X; Zhang R
    Life Sci; 2017 Sep; 185():85-94. PubMed ID: 28711488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypic characterization and therapeutics effects of human bone marrow- and umbilical cord-derived mesenchymal stromal cells in an experimental model of sepsis.
    Varkouhi AK; He X; Teixeira Monteiro AP; Amatullah H; Tsoporis JN; Gupta S; Ektesabi AM; Mei SHJ; Stewart DJ; Keating A; Dos Santos CC
    Exp Cell Res; 2021 Feb; 399(2):112473. PubMed ID: 33428902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-serial expression of toll-like receptor 4 signaling during polymicrobial sepsis in rats.
    Lee EP; Lin MJ; Wu HP
    Int J Immunopathol Pharmacol; 2022; 36():3946320221090021. PubMed ID: 35603454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of Ninjurin1 to Toll-like receptor 4 signaling and systemic inflammation.
    Jennewein C; Sowa R; Faber AC; Dildey M; von Knethen A; Meybohm P; Scheller B; Dröse S; Zacharowski K
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):656-63. PubMed ID: 25860173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-4-induced activation of the Stat6 pathway contributes to the suppression of cell-mediated immunity and death in sepsis.
    Song GY; Chung CS; Chaudry IH; Ayala A
    Surgery; 2000 Aug; 128(2):133-8. PubMed ID: 10922982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of dexmedetomidine on inflammatory response of septic rats.
    Zhang J; Wang Z; Wang Y; Zhou G; Li H
    BMC Anesthesiol; 2015 May; 15():68. PubMed ID: 25929655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HS-23, Lonicera japonica extract, attenuates septic injury by suppressing toll-like receptor 4 signaling.
    Kim SJ; Yoon SJ; Kim YM; Hong SW; Yeon SH; Choe KI; Lee SM
    J Ethnopharmacol; 2014 Aug; 155(1):256-66. PubMed ID: 24862492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease.
    de Witte SFH; Merino AM; Franquesa M; Strini T; van Zoggel JAA; Korevaar SS; Luk F; Gargesha M; O'Flynn L; Roy D; Elliman SJ; Newsome PN; Baan CC; Hoogduijn MJ
    Stem Cell Res Ther; 2017 Jun; 8(1):140. PubMed ID: 28595619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
    Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
    Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial Fusion Protein BPI21/LL-37 Modification Enhances the Therapeutic Efficacy of hUC-MSCs in Sepsis.
    Li Z; Song Y; Yuan P; Guo W; Hu X; Xing W; Ao L; Tan Y; Wu X; Ao X; He X; Jiang D; Liang H; Xu X
    Mol Ther; 2020 Aug; 28(8):1806-1817. PubMed ID: 32445625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.